Cognition Therapeutics' Angel Round

Cognition Therapeutics raised a round of funding on December 23, 2010. Investors include Golden Seeds.

Cognition Therapeutics is focused on the discovery and development of small molecule therapeutics targeting toxic proteins that cause the cognitive decline associated with Alzheimer's disease and othe…

Articles about Cognition Therapeutics' Angel Round: